Qilu Pharmaceutical Co., Ltd.
http://en.qilu-pharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Qilu Pharmaceutical Co., Ltd.
Asia Deal Watch: CStone Partners With LegoChem On Novel ADC Candidate
Plus deals involving Lilly/Daiichi Sankyo, Humianigen/KPM Tech, Telix/China Grand, Appili/Fujifilm, BioInvent/CASI, Osotec/Adel, Neumentum/Nuance, Takeda/HemoShear and Quantum Genomics/Qilu.
Some Companies Say 'No' To China's Latest VBP Round
Only three of 40 qualified international drug firms won in the latest round of China's central bidding process, showing a toughening environment. But some companies are seemingly determined not to lower prices any further.
China's Hengrui Halts Most Generic Development
China’s favorite domestic drug maker seems to have a warning for the industry - innovate or halt. After the recent round of “4+7” centralized procurement saw some off-patent drugs priced at pennies, the leading Chinese firm Hengrui has decided to halve its generics portfolio to focus on innovative new drugs.
Hengrui Halts Most Generic Development After Prices Free Fall In China
China’s favorite domestic drug maker seems to have a warning for the industry - innovate or halt. After the recent round of “4+7” centralized procurement saw some off-patent drugs priced at pennies, the leading Chinese firm Hengrui has decided to halve its generics portfolio to focus on innovative new drugs.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs